Picture shown is for illustrative purposes only. Britain has signed a supply deal for up to 60 million doses of a possible COVID-19 vaccine being developed by Sanofi and GlaxoSmithKline , it said on Wednesday, its fourth such arrangement. No vaccine has yet been approved to treat or prevent COVID-19, the respiratory disease caused by the coronavirus that has killed more than 659,000 people and unleashed economic havoc worldwide. READ MORE Fresh coronavirus cluster spreads to five Chinese regions WHO calls for quick response to virus resurgence Sharjah extends suspension of social activities until end of August Financial terms of the agreement were not disclosed. Sanofi and GSK, which had first teamed up in April, confirmed in a statement that regulatory approval for their vaccine could be won by the first half...read more...